Clinical grade ACE2 as a universal agent to block SARS‐CoV‐2 variants

…, A Bugajska‐Schretter, A Dohnal, C Ruf… - EMBO Molecular …, 2022 - embopress.org
The recent emergence of multiple SARS‐CoV‐2 variants has caused considerable concern
due to both reduced vaccine efficacy and escape from neutralizing antibody therapeutics. It is…

Effects of complement inactivation and IgG depletion on skin reactivity to autologous serum in chronic idiopathic urticaria

U Fagiolo, F Kricek, C Ruf, A Peserico… - Journal of allergy and …, 2000 - Elsevier
Background: Intradermal injection of autologous serum elicits a wheal-and-flare response in
about 60% of patients with chronic idiopathic urticaria (CIU). This reactivity has been …

Molecular basis for nonanaphylactogenicity of a monoclonal anti-IgE antibody

…, AW Zuercher, A Nechansky, C Ruf… - The Journal of …, 2000 - journals.aai.org
IgE Abs mediate allergic responses by binding to specific high affinity receptors (FcεRI) on
mast cells and basophils. Therefore, the IgE/FcεRI interaction is a target for clinical …

A Small Contribution to a Large System: The Leptin Receptor Complex

…, HTN Phan, Y Hu, EA Kurth, C Ruf… - The Journal of …, 2023 - ACS Publications
Obesity is a classified epidemic, increasing the risk of secondary diseases such as diabetes,
inflammation, cardiovascular disease, and cancer. The pleiotropic hormone leptin is the …

Epitope-specific antibody response to IgE by mimotope immunization

MP Rudolf, M Vogel, F Kricek, C Ruf… - The Journal of …, 1998 - journals.aai.org
We have previously described a mouse monoclonal anti-human IgE antibody (BSW17)
capable of recognizing receptor-bound IgE without inducing mediator release from human …

[HTML][HTML] Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants

…, AS Jimenez, A Bugajska-Schretter, A Dohnal, C Ruf… - BioRxiv, 2021 - ncbi.nlm.nih.gov
The recent emergence of multiple SARS-CoV-2 variants has caused considerable concern
due to reduced vaccine efficacy and escape from neutralizing antibody therapeutics. It is …

Mimicry of human IgE epitopes by anti-idiotypic antibodies

…, S Kuhn, AW Zürcher, MB Stadler, C Ruf… - Journal of molecular …, 2000 - Elsevier
According to Jerne’s network hypothesis, the binding site of an anti-idiotypic antibody also
represents the internal image of an epitope present on a foreign, or even a self antigen. In …

[HTML][HTML] A next generation peripherally restricted Cavα2δ-1 ligand with inhibitory action on Cav2. 2 channels and utility in neuropathic pain

F Kricek, C Ruf, P Meghani, IA Souza… - Biomedicine & …, 2024 - Elsevier
The Voltage-Gated Calcium Channel (VGCC) auxiliary subunit Cavα2δ-1 (CACNA2D1) is
the target/receptor of gabapentinoids which are known therapeutics in epilepsy and …

Designed ankyrin repeat proteins as anti‐idiotypic‐binding molecules

…, MJ Baumann, P Amstutz, C Ruf… - Annals of the New …, 2007 - Wiley Online Library
According to the network theory antibodies may act as antigens thus generating anti‐idiotypic
antibodies that can function as regulators of immune responses. Designed ankyrin repeat …

[HTML][HTML] The peptide TAT-I24 with antiviral activity against DNA viruses binds double-stranded DNA with high affinity

H Harant, S Höfinger, F Kricek, C Ruf, Z Ruzsics… - Biologics, 2021 - mdpi.com
The peptide TAT-I24, composed of the 9-mer peptide I24 and the TAT (48-60) peptide, exerts
broad-spectrum antiviral activity against several DNA viruses. The current model of the …